Ligufalimab is a kind of drug called a monoclonal antibody that targets the CD47 protein which is highly expressed by some cancers.
| SparkCures ID | 750 |
|---|---|
| Generic Name | AK117 |
| Additional Names | Ligufalimab |
| Treatment Classifications | |
| Treatment Targets |
There are no resources, links or videos to display for this treatment.